Pfizer Venture Investments pfizer.com/partnering/areas_of_interest/venture_investments.jsp

Pfizer Venture Investments (PVI), the venture capital arm of Pfizer, was founded in 2004 and invests for return in areas of current or future strategic interest to Pfizer. As part of the Worldwide Business Development, Strategy, and Innovation division, PVI seeks to remain at the forefront of life science advances, looking to identify and invest in emerging companies that are developing compounds and technologies that have the potential to enhance Pfizer's pipeline.

Pfizer Venture Investments (PVI), the venture capital arm of Pfizer, was founded in 2004 and invests for return in areas of current or future strategic interest to Pfizer. As part of the Worldwide Business Development, Strategy, and Innovation divisi...Show all

See All Exits Recent Exits

Phone:

Fax:

235 East 42nd Street

 New York, 10017
 New York, United States

Pfizer Venture Investments - Investments & Acquisitions

Show Real Data
See all Recent Investments
Date Company Round Amount Co-investors
2018-06-05Nimbus TherapeuticsSeries C$65MAtlas Venture, Bill Gates, Lightstone Ventures, Lilly Ventures, Schrodinger, and SR One
2018-05-31CortexymeSeries B$76MBreakout Ventures, Dolby Family Ventures, Epiq Capital, Huizenga Capital Management, RSL Investment, Sequoia Capital, Takeda Ventures, Verily Life Sciences, and Vulcan Capital
2018-05-11Strata OncologySeries B$26MArboretum Ventures, Baird Venture Partners, Deerfield Management, Merck Global Health Innovation Fund, and Renaissance Venture Capital
2018-04-02RefleXion MedicalSeries C$100MGT Healthcare Capital Partners, Johnson & Johnson Innovation, KCK Group, Sofinnova Partners, T. Rowe Price, The Rise Fund, and Venrock
2017-12-14Jnana TherapeuticsSeries A$50MAbbVie Biotech Ventures, Avalon Ventures, Polaris Partners, and Versant Ventures
See all 5 investments